| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |